Anakem Laboratories Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 1.00 M
- Company Age 61 Year, 3 Months
- Last Filing with ROC 31 Mar 2018
- Satisfied Charges ₹ 9.75 Cr
About Anakem Laboratories
Anakem Laboratories Pvt Ltd (ALPL) was founded in India on 21 November 1963 and has a glorious history of 61 years and three months.Its registered office is in Kolkata, West Bengal, India.
The Company is engaged in the Trading Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2018. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M.
The company has closed loans amounting to ₹9.75 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Sibani Maiti and Somsukla Maity serve as directors at the Company.
Company Details
- Location
Kolkata, West Bengal, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24231WB1963PTC025941
- Company No.
025941
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 Nov 1963
- Date of AGM
29 Sep 2018
- Date of Balance Sheet
31 Mar 2018
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Who are the key members and board of directors at Anakem Laboratories?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sibani Maiti  | Director | 02-May-2011 | Current |
| Somsukla Maity | Director | 28-Feb-2011 | Current |
Financial Performance of Anakem Laboratories.
Anakem Laboratories Pvt Ltd, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Anakem Laboratories?
In 2017, Anakem Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Urmi Lodging Private LimitedSibani Maiti is a mutual person
- United Vein Care Cancer Research & Welfare Institute Limited
Sibani Maiti and Somsukla Maity are mutual person
Charges (Loans)
₹0
₹97.50 M
Charges Breakdown by Lending Institutions
- State Bank Of India : 9.75 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 11 Jun 2004 | State Bank Of India | ₹9.75 Cr | Satisfied |
How Many Employees Work at Anakem Laboratories?
Anakem Laboratories has a workforce of 0 employees as of Mar 22, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Anakem Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Anakem Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
